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Abstract
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition
and Allergies (NDA) was asked to deliver a scientiﬁc opinion on the energy conversion factor of
D-tagatose to be used for calculating the energy value of foods to be declared in nutrition labelling.
Energy conversion factors for nutrients for the purpose of nutrition labelling have been set based on
the concept of metabolisable energy (ME). The same methodology has been applied to calculate the
energy conversion factor for D-tagatose in this opinion. The assessment is based on a dossier prepared
for Nutrilab NV and submitted by Bioresco Ltd. At present, data are insufﬁcient to derive an accurate
ME value for D-tagatose. Relying on the human data indicating a mean absorption rate of 80% (range
69–88%) and a urinary excretion of either 1% or 5%, the corresponding energy values for D-tagatose
would be 2.8 kcal/g (11.8 kJ/g) and 2.96 kcal/g (12.4 kJ/g), respectively. Taking into account that the
remaining 20% of D-tagatose which is not absorbed in the small intestine is fermented in the colon
and may deliver at least some energy, e.g. in form of short-chain fatty acids, the Panel concludes that
a rounded estimate of the energy conversion factor for D-tagatose based on the available data and
calculated as ME would be 3 kcal/g (12.5 kJ/g). The Panel considers that additional data on the
absorption, distribution, metabolism and excretion of D-tagatose in humans would help in the
calculation of a more accurate energy conversion factor for D-tagatose based on the concept of ME.
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Summary
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition
and Allergies (NDA) was asked to deliver a scientiﬁc opinion on the energy conversion factor of
D-tagatose to be used for calculating the energy value of foods to be declared in nutrition labelling.
The energy conversion factor should be established in a comparable way to the establishment of the
energy conversion factors for other nutrients that have been set for the purpose of nutrition labelling
such as carbohydrate (4–17 kJ/g), protein (4–17 kJ/g) or fat (9–37 kJ/g).
Energy conversion factors for nutrients for the purpose of nutrition labelling have been set based
on the concept of metabolisable energy (ME). The same methodology has been applied to calculate
the energy conversion factor for D-tagatose in this opinion.
The assessment of the energy conversion factor of D-tagatose is based on the dossier – summary of
the scientiﬁc evidence prepared for Nutrilab NV, Bekkevoort, Belgium, and submitted by Bioresco Ltd.
The energy content of food as measured by complete combustion is termed gross energy (GE).
The term ME encompasses the energy available after accounting for losses of the ingested energy in
faeces (FE), urine (UE), gases from fermentation in the large intestine (GaE) and waste products lost
from surface areas (SE). Not all ME is available for the production of adenosine triphosphate (ATP).
When energy losses as heat resulting from microbial fermentation and obligatory thermogenesis
(i.e. excess heat relative to glucose during ATP synthesis) are subtracted from ME, the result is an
expression of the energy content of food that will be available to the body for ATP production, which is
referred to as net metabolisable energy (NME).
Fractional absorption of D-tagatose in the small intestine in six human subjects and one pig was
around 80%. Under different experimental conditions, lower absorption rates in pigs of about 26% and
in rats of about 20% were also reported. Available studies in humans, pigs and rats consistently report
urinary losses of D-tagatose to range between about 1% and 5% of the ingested dose. It has been
also consistently shown in animals that most, if not all, of the D-tagatose not absorbed in the small
intestine is metabolised by the microbiota of the large intestine, and that there is an adaptive increase
in the fermentation capacity as a consequence of D-tagatose intake. However, it is unclear in which
proportions fermentation products of D-tagatose (i.e. short-chain fatty acids (SCFA), lactate, pyruvate,
hydrogen, methane) are formed by the microbiota of the large intestine and to which extent they are
available as energy source to humans.
The Panel notes that the energy conversion factors for labelling purposes in the European legislation
have been estimated as ME for other nutrients. At present, data are insufﬁcient to derive an accurate
ME value for D-tagatose. Based on a GE value for D-tagatose of 3.75 kcal/g (15.7 kJ/g), fractional
absorption rates of 20% (one study in rats), 25% (one study in pigs) and 80% (one human study on
ileostomy patients and one study in a pig) of the ingested amount, and urinary losses between 1% and
5%, ME values between 2.06 and 3.33 kcal/g (8.62 and 13.97 kJ/g) can be obtained, on the
assumption that fermentation yields only 50% of the GE of D-tagatose and that SE losses are negligible.
FSANZ (2004) assumes that fermentation yields 70% of the GE of D-tagatose and that 5% of fermented
D-tagatose is lost as GaE. This would result in ME values between 2.67 and 3.45 kcal/g (11.15 and
14.44 kJ/g). However, estimates for energy yield from fermentation of D-tagatose are based on multiple
assumptions that are not corroborated by experimental data in humans.
Relying on the human data indicating a mean absorption rate of 80% (range 69–88%) and a
urinary excretion of either 1% or 5%, the Panel considers that the corresponding energy values for
D-tagatose would be 2.8 kcal/g (11.8 kJ/g) and 2.96 kcal/g (12.4 kJ/g), respectively. Taking into
account that the remaining 20% of D-tagatose which is not absorbed in the small intestine is
fermented in the colon and may deliver at least some energy, e.g. in form of SCFA, the
Panel concludes that a rounded estimate of the energy conversion factor for D-tagatose based on the
available data and calculated as ME would be 3 kcal/g (12.5 kJ/g).
The Panel considers that additional data on the absorption, distribution, metabolism and excretion
of D-tagatose in humans would help in the calculation of a more accurate energy conversion factor for
D-tagatose based on the concept of ME.
Energy conversion factor of D-tagatose
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
Council Directive 90/496/EEC of 24 September 2000 on nutrition labelling for foodstuffs and amending
Directives 2003/120/EC and 2008/100/EC, speciﬁes the energy conversion factors that shall be used for
calculating the energy value to be declared in nutrition labelling. The Commission has received a request
from a company for the evaluation of the energy conversion factor of D-tagatose, a monosaccharide. The
energy conversion factor for carbohydrates is set in Directive 90/496/EEC at 4–17 kJ/g.
1.1.2. Terms of Reference
In accordance with Article 29 (1) (a) of Regulation (EC) No 1781/2002, the European Commission
asks the European Food Safety Authority (EFSA) to provide a scientiﬁc opinion on the energy
conversion factor of D-tagatose to be used for calculating the energy value of foods to be declared in
nutrition labelling. The energy conversion factor should be established in a comparable way to the
establishment of the energy conversion factors for other nutrients that have been set for the purpose
of nutrition labelling such as carbohydrate (4–17 kJ/g), protein (4–17 kJ/g) or fat (9–37 kJ/g).
1.2. Interpretation of the Terms of Reference
Council Directive 90/496/EEC has been repealed by Regulation (EC) No 1169/20111, which
establishes in Annex XIV the conversion factors to be used for the calculation of the energy content to
be declared in food labels. The European Commission requests that the energy conversion factor for
D-tagatose should be established in a comparable way to the establishment of the energy conversion
factors for other nutrients, such as carbohydrate (4–17 kJ/g), protein (4–17 kJ/g) or fat (9–37 kJ/g).
EFSA notes that the energy conversion factors that have been set in Regulation (EC) No 1169/2011 for
the above-mentioned macronutrients for the purpose of nutrition labelling are the same as in Council
Directive 90/496/EEC, and that those values were calculated using the concept of metabolisable
energy (ME). The European Commission conﬁrmed this view. Therefore, EFSA interprets this mandate
as a request for a scientiﬁc opinion on the energy conversion value of D-tagatose to be used for
calculating the energy value of foods to be declared in nutrition labelling based on the concept of ME.
2. Data and methodologies
2.1. Data
The assessment of the energy conversion factor of D-tagatose is based on the dossier – summary
of the scientiﬁc evidence prepared for Nutrilab NV, Bekkevoort, Belgium. Date: 7 April 2008. Submitted
by Bioresco Ltd.
2.2. Methodologies
Energy conversion factors for nutrients for the purpose of nutrition labelling have been set based
on the concept of ME. The same methodology will be applied to calculate the energy conversion factor
for D-tagatose in this opinion.
3. Assessment
3.1. Introduction
D-Tagatose is a monosaccharide that was authorised as a novel food in the European Union (EU) in
June 2005 based on an opinion of the UK Advisory Committee for Novel Foods and Processes (ACNFP)
(FSA, 2005). The estimated daily intakes of D-tagatose considered in the different safety assessments
1 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and
of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC,
Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and
Commission Regulation (EC) No 608/2004. OJ L 304, 22.11.2011, p. 18.
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vary from about 4–5 g/day for the mean consumer to about 10 g/day for the 90th percentile
consumer, but higher intakes of 15–20 g/day are conceivable (FSA, 2005).
In recognition of the need for the allocation of an appropriate energy conversion factor for
D-tagatose for labelling purposes, the US Food and Drug Administration (US FDA) has accepted a
factor of 1.5 kcal/g (6 kJ/g) (FDA, 2001). In Australia/New Zealand, a factor of 2.5 kcal/g (11 kJ/g)
was attributed to D-tagatose for that purpose (FSANZ, 2004). Regulation (EC) No 1169/20111
(repealing Council Directive 90/496/EEC on nutrition labelling for foodstuffs, as amended) speciﬁes that
the energy conversion factors that shall be used for calculating the energy value to be declared in
nutrition labelling for glycaemic carbohydrates is 17 kJ/g (4 kcal/g).
The energy content of food as measured by complete combustion is termed gross energy (GE).
The term ME encompasses the energy available after accounting for losses of the ingested energy in
faeces (FE), urine (UE), gases from fermentation in the large intestine (GaE), and waste products lost
from surface areas (SE). Not all ME is available for the production of adenosine triphosphate (ATP).
When energy losses as heat resulting from microbial fermentation and obligatory thermogenesis
(i.e. excess heat relative to glucose during ATP synthesis) are subtracted from ME, the result is an
expression of the energy content of food that will be available to the body for ATP production, which is
referred to as net metabolisable energy (NME) (FAO, 2003).
In the EU legislation, the energy conversion factors for nutrients for labelling purposes have been
calculated as ME.
3.2. Characterisation and intended use
D-Tagatose is a naturally occurring, sweet ketohexose related to D-galactose and is the C-4 epimer
of D-fructose. D-Tagatose occurs in Sterculia setigera gum, a partially acetylated acidic polysaccharide,
and also in low concentrations in heated cow’s milk produced from lactose (FSA, 2005). D-Tagatose
was originally developed as a sugar substitute for energy and weight control and has been used as
low-energy sweetener in soft drinks and yoghurts.
3.3. Absorption, metabolism and excretion
3.3.1. Absorption
There is only one human study investigating the absorption of D-tagatose. Normen et al. (2001)
administered a controlled diet with 15 g of D-tagatose daily for 3 weeks to six subjects with ileostomy,
with less than 10 cm of the terminal ileum removed due to ulcerative colitis. Subjects were otherwise
healthy and the time since the operation ranged between 5 and 27 years. Ileostomy efﬂuents were
collected every second hour to minimise bacterial degradation. The bags were immediately sealed and
frozen in containers ﬁlled with dry ice. Mean recovery of the ingested D-tagatose over 24 h in the
ileostomy was about 19%, leading to a mean apparent absorption of 81% (range 69–88%).
An absorption study (Levin et al., 1995, unpublished report) was performed in one pig fed with 5%
of D-tagatose in the diet, which was restricted to 85% of its normal quantity of feed. In addition,
bacteriostatics were included as well as Celite, an insoluble ash, as inert markers. Analyses of samples
of digested material, removed hourly from the cannulated ileum over a period of 8 h, showed that
78% of the D-tagatose was absorbed from the small intestine.
In a study in eight pigs fed twice daily a restricted diet (40 g/kg body weight per day) containing
10% D-tagatose for 18 days, a mean ( SEM) digestibility of D-tagatose of 25.8% ( 5.6) was
reported, as determined in the distal third of the small intestine (Laerke and Jensen, 1999). Chromic
oxide was used as a digestibility marker. In this study, the pigs were killed 3 h after the morning meal,
the gastrointestinal tract was removed and its contents analysed. The digestibility was calculated from
the concentration of D-tagatose in the intestinal content in relation to its concentration in the diet.
A third study in pigs (Johansen and Jensen, 1997) was available to the Panel only as an abstract
and thus could not be evaluated.
One study in rats reported an intestinal absorption rate of D-tagatose of about 20% (Saunders
et al., 1999) based on results obtained in two germ-free unadapted rats to which a single dose of
[U-14C]-labelled D-tagatose was orally administered. Intestinal absorption was estimated from the sum
of 14C expired as 14CO2 and recovered in tissues and carcass 6 h after dosing, assuming that this time
frame reﬂects absorption and metabolism of absorbed nutrients by mammalian enzymes in rats.
Energy conversion factor of D-tagatose
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3.3.2. Metabolism
It has been proposed that the absorbed D-tagatose could be metabolised in the liver via a pathway
similar to that of D-fructose. D-Tagatose is phosphorylated to D-tagatose 1-phosphate by fructokinase
(Raushel and Cleland, 1973) and then cleaved by aldolase B to enter glycolysis at the level of
D-glyceraldehyde and dihydroxyacetone phosphate (Martınez et al., 1987).
3.3.3. Excretion
In a human study on eight volunteers on a diet providing 30 g/day of D-tagatose for 2 weeks, urinary
excretion of D-tagatose ranged between 0.7% and 5.3% of the ingested dose (Buemann et al., 1998).
No or negligible amounts of D-tagatose were found in faeces of pigs ingesting a 10% D-tagatose
diet for 14 consecutive days (Laerke and Jensen, 1999). Negligible amounts of D-tagatose in faeces
were also reported in pigs on either a 10% or 20% D-tagatose diet, whereas about 5% of the ingested
D-tagatose was excreted in urine, irrespective of whether the diet contained 10% or 20% of
D-tagatose, and 2% was lost as hydrogen (Jørgensen and Laerke, 1998; unpublished report).
In adapted rats fed a diet with 10% D-tagatose for 28 days, a total of 9% of the ingested dose of
14C-labelled D-tagatose was recovered in faeces after 24 h. About 1.8% of the 14C was found in
D-tagatose and 1.3% in short-chain fatty acids (SCFA), pyruvate and lactate. The fate of the remaining
5.9% of 14C was not further speciﬁed (Saunders et al., 1999). After 72 h, the total percentage of the
14C dose recovered in faeces was 11.4%, while in the unadapted rats, the recovery of D-tagatose in
faeces was about 28.7% of the ingested dose.
In rats and pigs, increased numbers of D-tagatose degrading bacteria and disappearance of watery
stools after few days of D-tagatose ingestion indicate adaptation of the microbiota to the consumption
of D-tagatose (Laerke and Jensen, 1999; Saunders et al., 1999). D-Tagatose did not appear to be
utilised as a substrate by the microbiota in the stomach and small intestine of pigs, whereas it was
readily fermented by the microbiota in the caecum and colon (Laerke et al., 2000). It was estimated
that about 51% of the energy of D-tagatose is recovered as SCFA when D-tagatose is fermented
in vitro by adapted caecal and colonic bacteria (Laerke et al., 2000).
The mean recovery over a period of 72 h of 14CO2 in breath from
14C-labelled D-tagatose given
orally to adapted rats was 67.9% (Levin et al., 1995; Saunders et al., 1999), while in germ-free
animals, the recovery was only 22% (Saunders et al., 1999). This suggests that the observed
difference in the expired 14CO2 between adapted and germ-free rats may have derived from bacterial
metabolism. In this study, the percentage of the 14C dose recovered in urine and carcass of adapted
rats amounted to 5.2% and 10.1%, respectively. This indicates that a total of 83.2% of the ingested
radiolabelled D-tagatose has been absorbed (either as D-tagatose in the small intestine or as SCFA and
other degradation products of the microbiota in the large intestine), of which 78% has been
metabolised (67.9%) or retained (10.1%).
The Panel notes that fractional absorption of D-tagatose in the small intestine in six human subjects
and one pig was around 80%. Under different experimental conditions, lower absorption rates in pigs
of about 26% and in rats of about 20% were also reported. Available studies in humans, pigs and rats
consistently report urinary losses of D-tagatose to range between about 1% and 5% of the ingested
dose. It has been also consistently shown in animals that most, if not all, of the D-tagatose not
absorbed in the small intestine is metabolised by the microbiota of the large intestine, and that there is
an adaptive increase in the fermentation capacity as a consequence of D-tagatose intake. However, it is
unclear in which proportions fermentation products of D-tagatose (i.e. SCFA, lactate, pyruvate,
hydrogen, methane) are formed by the microbiota of the large intestine and to which extent they are
available as energy source to humans.
3.4. Methods
The energy value of foods or food constituents may be estimated either directly from results of
in vivo studies (e.g. energy balance studies, indirect calorimetry) or from data on their metabolic fate
(factorial calculation model). ME can be determined using the factorial calculation model according to
the following formula: ME = GE  (FE + UE + GaE + SE).
3.4.1. Energy balance methods
Three in vivo studies on the energy value of D-tagatose were provided by the applicant.
Energy conversion factor of D-tagatose
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In one study conducted in rats (unpublished report of Biospherics Inc. by Saunders et al., 1994),
the retained energy was calculated to be 0 kJ/g D-tagatose. Calculations of either ME or NME were not
performed, and therefore, no conclusions can be drawn from this study to estimate the energy
conversion factor for D-tagatose.
The second study examined the contribution of D-tagatose to energy requirements in growing rats
by determining its NME value (Livesey and Brown, 1996). Two groups of 30 rats each were adapted
for a period of 21 days to a basal diet supplemented with either sucrose (5%) or D-tagatose (10%).
Each group was then split at random into three subgroups. One of the subgroups continued the
assigned treatment for 40 days, one discontinued the treatment (i.e. basal diet without supplement for
40 days), and one was killed for body composition analysis. The daily intake of the basal diet was
ﬁxed. Body weights were determined at the start of the experiment, at the end of the 21-day
adaptation period, and at the end of the 40-day balance period. The GE of the basal diet, of
D-tagatose and of sucrose was also determined. From these data, it was calculated that D-tagatose had
a NME of 0.12 kcal/g (0.5 kJ/g).
The Panel notes that other studies have shown that D-tagatose is absorbed at least to some extent
in the small intestine in rats (Jørgensen and Laerke, 1998; Saunders et al., 1999) and to a greater
extent in humans (Normen et al., 2001), and that otherwise, it is nearly completely fermented by the
microbiota in the large intestine (Laerke and Jensen, 1999). Thus, the results reported by Livesey and
Brown (1996) lack biological plausibility, which might be attributed to the study design or the
methodology applied.
In the third study (Jørgensen and Laerke, 1998; unpublished report), six growing pigs received
randomly three diets containing either 20% sucrose, 10% sucrose and 10% D-tagatose, or 20%
D-tagatose during 2 weeks each. During the second week, faecal digestibility of dietary nutrients was
estimated, and protein, fat and energy balance, urinary output of D-tagatose, amount of methane and
hydrogen expired, and the faecal composition and output of SCFA and lactate were analysed.
Digestible energy (DE) was estimated based on indirect calorimetry measurements and on nitrogen
and carbon balance. The energy utilisation of GE from either basal diet plus sucrose and/or D-tagatose
(MJ/day) was regressed to the daily total amount of the measured parameters DE
(DE = GE  FE  GaE), CH4 energy, H2 energy, urine energy and ME in MJ/day. Energy digestibility
decreased from 85.3% to 79.8% when replacing 20% sucrose with 20% D-tagatose. The energy
digestibility in the total ration decreased by 0.292% for each per cent inclusion of D-tagatose in the
diet, when assuming a linear response. From the equation DE/GE, % = 85.8  0.292 9 D-tagatose %,
the digestibility of D-tagatose was calculated as 56.6%.
Although a linear response was assumed, the authors noted that the data points could also indicate
a curvilinear function with a smaller response with the 10% D-tagatose diet than with the 20%
D-tagatose diet. When metabolisability (ME/GE) of D-tagatose was estimated by the difference method
in this study, using literature values for sucrose, the resulting values for the 10% and 20% D-tagatose
diets were 74% and 57%, respectively.
About 5% of the ingested D-tagatose was excreted in the urine, independently of the intake of
D-tagatose at either 10% or 20% in the diet, and 2% lost as hydrogen. Only minor or no losses of
D-tagatose were observed in faeces and D-tagatose did not contribute to methane excretion.
Calculating the ME of D-tagatose as the difference between GE (15.67 kJ) and FE
(15.67  15.67 9 0.566), UE (5% of GE) and GaE (2% of GE), a value of 1.9 kcal/g (7.9 kJ/g) was
obtained using the value of 56.6% for DE for the 20% level of D-tagatose. Using the reported value of
74% for ME derived from the difference method for the 10% level of D-tagatose, this would yield
an energy value of 2.8 kcal/g (11.6 kJ/g), although this value was not explicitly considered by
the authors.
The Panel notes that, out of the three animal studies provided using energy balance methods, only
one study in six pigs (Jørgensen and Laerke, 1998; unpublished report) provided data for calculating
the ME of D-tagatose. Depending on the dose of D-tagatose and the calculation approach, the results
suggest values of either 1.9 kcal/g (7.9 kJ/g) or 2.8 kcal/g (11.6 kJ/g).
3.4.2. Factorial calculation
The applicant presents an estimation of the energy value of D-tagatose using the factorial model,
taking into account losses of energy caused indirectly by the fermentation of D-tagatose
(e.g. increased faecal excretion of biomass and non-bacterial mass).
Energy conversion factor of D-tagatose
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3.4.2.1. Energy gain from absorbed and metabolised D-tagatose
The calculation of the energy gain from absorbed and metabolised D-tagatose conducted by the
applicant assumes that the fractional absorption of D-tagatose is 25% as reported in rats and pigs
(Jensen and Laue, 1998; Laerke and Jensen, 1999; Saunders et al., 1999) and that 5% of the
ingested D-tagatose is lost in urine as reported in rats (Saunders et al., 1999). Based on the results
from the metabolic studies in rats, the applicant assumed that the absorbed fraction of D-tagatose
which is not excreted in urine is fully metabolised, which would yield 3.75 kcal/g (15.7 kJ/g). From
this, the applicant calculated that the energy gain from absorbed and metabolised D-tagatose would be
0.75 kcal/g (3.14 kJ/g) of ingested D-tagatose.
The Panel notes that a fractional absorption rate of 80% has been reported in patients with
ileostomy (Normen et al., 2001) and also in a study in one pig, and that 1–5% of ingested D-tagatose
was recovered in urine in humans (Buemann et al., 1998; Buemann et al., 2000). The Panel also notes
that the ileostomy model has been widely used in other absorption studies in humans (e.g. Sandberg
et al., 1981; Chapman et al., 1985; Faulks et al., 1997; Witth€oft et al., 2006) and considers that this
model represents an appropriate approach to estimate absorption of nutrients in healthy humans.
Assuming a fractional absorption of D-tagatose in the small intestine of 80% and urinary losses of
either 1% or 5%, the energy gain from absorbed and metabolised D-tagatose would be 2.96 and
2.81 kcal/g (12.40 and 11.78 kJ/g), respectively.
3.4.2.2. Energy gain from the absorbed short-chain fatty acids
The applicant assumes that 75% of the ingested D-tagatose is unabsorbed and fully subjected to
bacterial fermentation. In this situation, the SCFAs produced during bacterial fermentation would
account for about 50% of the GE (combustible energy) of D-tagatose. This assumption is based on
studies in pigs (Jensen and Laue, 1998; Laerke et al., 2000) and in humans (Jensen and Buemann,
1998). By applying a correction factor to account for a lower ATP yield from SCFA than from glucose
(0.85 mol ATP/kJ SCFA per mol ATP/kJ glucose), the energy gain from absorbed SCFA would be
1.26 kcal/g (B€ar, 1990; Livesey, 1993).
The Panel notes that the correction for a lower ATP yield from SCFA than from glucose does not
apply to the calculation of ME, but rather to the calculation of NME.
3.4.2.3. Energy loss due to increased faecal biomass
Assumptions on the energy loss due to increased faecal biomass rely on studies investigating the
increase in biomass due to the ingestion of fermentable substrates that stimulate bacterial growth.
From experiments with lactulose (Weber et al., 1987), lactitol (van Velthuijsen and De Uyl, 1988) and
isomalt (Livesey, 1990), the increase in biomass was estimated to be about 14–20% of the ingested
amount of fermentable substance. However, the incorporation into the biomass of 14C from 14C-lactitol
was only 6.5% (Grimble et al., 1988), 10% from 14C-isomalt (Patzschke et al., 1975; WHO, 1987) and
4.9% from 14C-maltitol (Rennhard and Bianchine, 1976). Up to 6% of 14C from 14C-D-tagatose orally
administered to rats was incorporated into faecal biomass.
The applicant argues that the difference between the increased faecal excretion of biomass (about
14–20% of the fermented substrate) and the much lower incorporation of C-atoms from the substrate
to the biomass (about 5–10%) suggests that the growing microbial cells incorporate C-atoms also from
other sources, which then would not be available to the host. The estimated maximum increase in
faecal biomass would be 15–20% of the fermented D-tagatose, and the estimated maximum
incorporation of C-atoms from D-tagatose to the biomass would be 5–10%. The average difference of
10% would represent other material incorporated into the biomass, which would result in an
energy loss for the host of about 0.2–0.4 kcal/g (0.8–1.7 kJ/g) of the fermented D-tagatose or
0.15–0.30 kcal/g (0.63–1.26 kJ/g) of the ingested D-tagatose, assuming that 25% is absorbed and
75% is fermented.
The Panel notes that no in vivo studies were provided which investigated the effects of D-tagatose
on faecal biomass directly, and that the effects of lactulose, lactitol and isomalt on faecal biomass may
differ from those of D-tagatose.
3.4.2.4. Energy loss due to increased faecal non-biomass
The increase in faecal dry matter in pigs fed a diet with 20% D-tagatose was 0.27 g/g of D-tagatose
ingested, and was calculated to be 0.36 g/g of D-tagatose fermented (unpublished report, Jørgensen
and Laerke, 1998). On the assumption that the bacterial growth yield is about 15–20% of the
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D-tagatose ingested (i.e. 0.15–0.20 g/g D-tagatose), half of the increased faecal dry matter would
represent bacteria (i.e. biomass), while the other half would represent a different material. Assuming
that this material was secreted protein (mucus, mucosal cells), the applicant calculated that the loss of
energy due to increased faecal non-biomass would be from 0.6 to 0.8 kcal/g (from 2.5 to 3.4 kJ/g) of
D-tagatose fermented, or from 0.45 to 0.60 kcal/g (from 1.9 to 2.5 kJ/g) of D-tagatose ingested.
The Panel notes that the calculations made by the applicant to derive the energy losses due to
increased faecal biomass and non-biomass are based on numerous assumptions which are not
substantiated with corresponding experiments.
3.5. Estimation of the energy conversion factor for D-tagatose
On the basis of the calculations and assumptions referred to in Sections 3.4.1 and 3.4.2, the
applicant derived an energy conversion factor for D-tagatose of 1.1–1.4 kcal/g (4.6–5.9 kJ/g) which
reﬂects NME, rather than ME.
The Panel notes that the energy conversion factors for labelling purposes in the European legislation
have been estimated as ME for other nutrients. At present, data are insufﬁcient to derive an accurate
ME value for D-tagatose. Based on a GE value for D-tagatose of 3.75 kcal/g (15.7 kJ/g), fractional
absorption rates between 20% (one study in rats), 25% (one study in pigs), 80% (one human study on
ileostomy patients and one study in a pig) of the ingested amount, and urinary losses between 1% and
5%, ME values between 2.06 and 3.33 kcal/g (8.62 and 13.97 kJ/g) can be obtained, on the
assumption that fermentation yields only 50% of the GE of D-tagatose and that SE losses are negligible.
FSANZ (2004) assumes that fermentation yields 70% of the GE of D-tagatose and that 5% of fermented
D-tagatose is lost as GaE. This would result in ME values between 2.51 and 3.45 kcal/g (10.51 and
14.44 kJ/g). However, estimates for energy yield from fermentation of D-tagatose are based on multiple
assumptions that are not corroborated by experimental data in humans.
4. Conclusions
Relying on the human data indicating a mean absorption rate of 80% (range 69–88%) and a
urinary excretion of either 1% or 5%, the corresponding energy values for D-tagatose would be
2.8 kcal/g (11.8 kJ/g) and 2.96 kcal/g (12.4 kJ/g), respectively. Taking into account that the remaining
20% of D-tagatose which is not absorbed in the small intestine is fermented in the colon and may
deliver at least some energy, e.g. in form of SCFA, the Panel concludes that a rounded estimate of the
energy conversion factor for D-tagatose based on the available data and calculated as ME would be
3 kcal/g (12.5 kJ/g).
5. Recommendations
The Panel considers that additional data on the absorption, distribution, metabolism and excretion
of D-tagatose in humans would help in the calculation of a more accurate energy conversion factor for
D-tagatose based on the concept of ME.
Steps taken by EFSA
1) The European Commission received a scientiﬁc dossier for the evaluation of the energy
conversion factor of D-tagatose (i.e. dossier on the energy conversion factor of D-tagatose –
summary of the scientiﬁc evidence prepared for Nutrilab NV, Bekkevoort, Belgium. Date: 7
April 2008. Submitted by Bioresco Ltd).
2) On 22 January 2009, the Commission forwarded the scientiﬁc dossier to EFSA and requested
EFSA to deliver a scientiﬁc opinion on the energy conversion factor of D-tagatose.
3) On 18 February 2009, EFSA accepted the mandate and agreed to ﬁnalise the scientiﬁc
opinion by May 2010.
4) On 17 May 2010, EFSA informed the Commission that the preparatory work for the draft
scientiﬁc opinion on the energy conversion factor of D-tagatose was done by the Working
Group on Population Reference Intakes (WG on PRI) and that the draft opinion was
discussed at the Plenary meeting of the NDA Panel on 28–30 April 2010. However, the
Panel found that the opinion required a revision, and thus EFSA requested to postpone the
deadline until July 2010.
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5) On 7 July 2010, EFSA informed the Commission that the WG on PRI found that there were
important data missing to calculate a scientiﬁcally sound energy conversion factor based on
ME for D-tagatose. A list of questions was prepared by EFSA to be forwarded to the applicant
in this respect. EFSA also requested conﬁrmation from the Commission that the energy
conversion factors for nutrients to be used for calculating the energy value of foods to be
declared in nutrition labelling should be based on the concept of ME, rather than on the
concept of NME.
6) On 2 August 2010, the Commission conﬁrmed that the energy conversion factors for
nutrients to be used for calculating the energy value of foods to be declared in nutrition
labelling should be based on the concept of ME. The Commission also informed EFSA that
the Commission will forward the EFSA requests for additional information to the applicant
and will send to EFSA the additional information submitted by the applicant once available.
7) On 9 February 2016, the Commission informed EFSA that, on 5 November 2015, the
applicant had informed the Commission that no new evidence was available which could be
used for calculating the energy conversion factor of D-tagatose based on the concept of ME,
and that the applicant had only summarised again its position by using supporting references
(additional information submitted by the applicant to the European Commission on April
2014). EFSA was requested by the Commission to provide a scientiﬁc opinion based on the
original request and the new references provided by the applicant. The Commission also
requested EFSA to propose a new deadline for the request considering the current workload
of EFSA.
8) On 23 February 2016, EFSA proposed the deadline of 31 December 2016 for the completion
of the request. EFSA also informed the Commission about the necessity of a public
consultation before adoption of this opinion.
9) On 29 June 2016, the NDA Panel endorsed a Draft Scientiﬁc Opinion on the energy
conversion factor of D-tagatose for labelling purposes for public consultation.
10) The written public consultation for this document was open from 18 July to 12 September
2016.
11) On 25 October 2016, the NDA Panel endorsed a technical report in which all comments
received during the public consultation were addressed and adopted this scientiﬁc opinion.
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ACNFP UK Advisory Committee for Novel Foods and Processes
ATP adenosine triphosphate
DE digestible energy
GaE energy lost in gases from intestinal fermentation
GE gross energy
FE energy lost in faeces
FDA US Food and Drug Administration
FSA Food Standards Agency
FSANZ Food Standards Agency Australia/New Zealand
Energy conversion factor of D-tagatose
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2016;14(11):4630
ME metabolisable energy
NDA EFSA Panel on Dietetic Products, Nutrition and Allergies
NME net metabolisable energy
SCFA short-chain fatty acids
SE energy lost in surface areas
SEM standard error of the mean
UE energy lost in urine
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